The Paediatric EVICEL® Soft Tissue and Parenchymal Organ Bleeding Study

NCT02227706 PHASE3 COMPLETED Results posted

To evaluate the safety and effectiveness of EVICEL® Fibrin Sealant (Human) as an adjunct to achieve haemostasis during surgery in paediatric patients.

Details

Lead sponsor	Ethicon, Inc.
Phase	PHASE3
Status	COMPLETED
Enrolment	40
Start date	Fri Aug 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Fri May 17 2019 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Hemorrhage
• Soft Tissue Bleeding

Interventions

• EVICEL® Fibrin Sealant
• SURGICEL® Absorbable Hemostat

Countries

Belgium, United Kingdom, Canada